Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020692

SEREVENT (SALMETEROL XINAFOATE)
EQ 0.05MG BASE/INH
Marketing Status: Prescription
Active Ingredient: SALMETEROL XINAFOATE
Proprietary Name: SEREVENT
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: EQ 0.05MG BASE/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020692
Product Number: 001
Approval Date: Sep 19, 1997
Applicant Holder Full Name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY LTD ENGLAND
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English